UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000019932
Receipt number R000023012
Scientific Title An exploratory research of minute radiation myocardium disorder by the added electrocardiogram device.
Date of disclosure of the study information 2015/12/15
Last modified on 2015/12/15 22:58:07

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

An exploratory research of minute radiation myocardium disorder by the added electrocardiogram device.

Acronym

An exploratory research of minute radiation myocardium disorder by the added electrocardiogram device.

Scientific Title

An exploratory research of minute radiation myocardium disorder by the added electrocardiogram device.

Scientific Title:Acronym

An exploratory research of minute radiation myocardium disorder by the added electrocardiogram device.

Region

Japan


Condition

Condition

several cancers received irradiation to the chest

Classification by specialty

Cardiology Radiology Adult

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

to identify minute radiation myocardium disorder by the added electrocardiogram device

Basic objectives2

Safety

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

the presence or absence of late potential by the added electrocardiogram before RT(control), just after RT, 3 months after RT, 6 months after RT
1. FQRS-D(Filtered QRS-Duration) more than 114ms
2. RMS40ms(Root-Mean-Square voltage of the signals in the last 40ms) less than 20uV
3. LAS40uV(the duration of the Low-Amplitude Signal after the voltage decreased to less than 40uV) more than 38msec
LP positive means more than 2 items abnormality.

Key secondary outcomes

Echocardiogram; ejection fraction, E/E, TEI index
MRI; late enhancement of ventricular septum
123I-BMIPP; down take of 123I-BMIPP


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Prevention

Type of intervention

Device,equipment

Interventions/Control_1

Before RT, just after RT, 3 months after RT, 6 months after RT.
the added electrocardiogram device
echo-cardiogram
MRI(if possible)
123I-BMIPP(if possible)

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

80 years-old >=

Gender

Male and Female

Key inclusion criteria

patients who received thoracic radiotherapy, and unavoidable cardiac irradiation.
age of 20 to 80 years old at the informed consent
Eastern Cooperative Oncology Group performance status of 0 or 1
over 1 year prognosis
written informed concent

Key exclusion criteria

under 1 year prognosis
skin disease
pacemaker
claustrophobia
drug hypersensitivity
psychiatric disorder
unstable angina and myocardial infarction
not allowing participation into this protocol

Target sample size

40


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Tohru Okada

Organization

Nagoya University Graduate school of Medicine

Division name

Department of Radiology

Zip code


Address

65 Tsurumai, Syouwa-ku, Nagoya city

TEL

052-744-2328

Email

tohruokada@med.nagoya-u.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Tohru Okada

Organization

Nagoya University Graduate school of Medicine

Division name

Department of Radiology

Zip code


Address

65 Tsurumai, Syouwa-ku, Nagoya city

TEL

052-744-2328

Homepage URL


Email

tohruokada@med.nagoya-u.ac.jp


Sponsor or person

Institute

Nagoya University Graduate school of Medicine

Institute

Department

Personal name



Funding Source

Organization

Nagoya University Graduate school of Medicine

Organization

Division

Category of Funding Organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2015 Year 12 Month 15 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2015 Year 11 Month 27 Day

Date of IRB


Anticipated trial start date

2016 Year 01 Month 04 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2015 Year 11 Month 25 Day

Last modified on

2015 Year 12 Month 15 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000023012


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name